The International Trade Commission published notices in the April 8 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website April 7, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
The International Trade Commission seeks comments by April 16 on a Section 337 complaint alleging that imports of drug products containing C-Type natriuretic peptide variants infringe patents held by BioMarin Pharmaceutical Inc., it said in a notice set for April 8 publication. According to the complaint, BioMarin is seeking a limited exclusion order and cease and desist orders against Ascendis Pharma and Wacker Biotech to bar from entry "drug products containing a c-type natriuretic peptide variant, and components of the drug product; specifically, a prodrug of CNP, including the drug substance, the linker of the drug substance, and other components, such as the synthetic polymeric group, and vials, prefilled syringes, autoinjectors, or other presentations of TransCon CNP containing the same, for the treatment of achondroplasia," that violate the complainant's patents. The complainant said that the drugs "have not been approved by the U.S. Food and Drug Administration for any indication, but are expected to be used for therapeutic purposes, such as treating achondroplasia in children."
The Commerce Department made final affirmative antidumping duty determinations that imports of epoxy resins from China (A-570-166), India (A-533-926), South Korea (A-580-919), Taiwan (A-583-876) and Thailand (A-549-850) are being sold in the U.S. at less than fair value. The agency imposed AD cash requirements retroactively on entries of subject merchandise from China beginning Aug. 15, 2024. For Indian, South Korean, Taiwanese and Thai exporters, suspension of liquidation and cash deposit requirements will continue for entries on or after Nov. 13, 2024, the date that the preliminary determinations were published in the Federal Register. Cash deposit rates set in these final determinations are effective April 3.
The International Trade Commission published notices in the April 4 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The International Trade Commission has ended a Section 337 investigation on imported capacitive discharge ignition systems (ITC Inv. No. 337-TA-1390), it said in a Federal Register notice published April 4. Complainant Altronic initially alleged in 2024 that Motortech was making ignition systems for industrial internal combustion engines that copy its patented technologies (see 2402130036).
The Commerce Department issued its final determination in its countervailing duty investigation of 2,4-dichlorophenoxyacetic acid, also known as 2,4-D, from China (C-570-161) and India (C-533-923), finding countervailable subsidization of producers and exporters in the two countries. Suspension of liquidation is currently not in effect for entries on or after Jan. 11, 2025, and Commerce will require cash deposits of estimated CVD on future entries only if it issues a CVD order.
The Commerce Department issued a final antidumping duty determination finding that imports of 2,4-dichlorophenoxyacetic acid, also known as 2,4-D, from China (A-570-160) and India (A-533-922) are being sold in the U.S. at less than fair value. Suspension of liquidation and cash deposit requirements will continue for entries on or after Nov. 14, the date that the preliminary determinations were published in the Federal Register. Cash deposit rates set in these final determinations take effect April 7.
The International Trade Commission published notices in the April 3 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The International Trade Commission published notices in the April 2 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):